Skip to main content
Clinical Trials/NCT05815693
NCT05815693RecruitingNot Applicable

Evaluate the Effectiveness for Long-term Consequences of COVID-19 of Mindfulness-based Stress Reduction (MBSR)

Azienda Socio Sanitaria Territoriale di Lecco2 sites in 1 country140 target enrollmentStarted: April 13, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
140
Locations
2
Primary Endpoint
Chronic pain

Study Overview

Brief Summary

The consequences of the Intensive Care Unit and the Covid-19 disease are still uncertain. However, many studies are bringing out often psychological and dramatic consequences for many COVID-survivor patients.

Among the ex-covid patients discharged from our Intensive Care Unit and with at least one covid-related psychological consequence, we want to evaluate the effectiveness for long-term consequences of COVID-19 of mindfulness-based stress reduction (MBSR) or usual care.

Detailed Description

Randomized controlled clinical study. All patients who survived COVID-19 and discharged from the intensive care unit of the Lecco hospital will be enrolled if present: chronic pain, anxiety, depression and/or insomnia in pharmacological therapy A group of patients will be observed during 12 months and evaluated with rating scales for chronic pain, anxiety, depression and insomnia.

The second (experimental) group will receive psychotherapy (mindfulness-based stress reduction and cognitive behavioral therapy) in addition to the pharmacological therapy

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Intensive care survivors
  • Surviving COVID-19 patients
  • Patients with Chronic Pain Anxiety Depression and/or Insomnia in drug therapy

Exclusion Criteria

  • Patients with Chronic Pain Anxiety Depression and/or Insomnia NOT in drug therapy
  • Patients not hospitalized in intensive care for COVID-19

Outcomes

Primary Outcomes

Chronic pain

Time Frame: 6 months and 1 year

pain that persists or recurs for longer than 3 months, and it exerts an enormous personal and economic burden, affecting more than 30% of people worldwide

Insomnia

Time Frame: 6 months and 1 year

a common sleep disorder that can make it hard to fall asleep, hard to stay asleep, or cause you to wake up too early and not be able to get back to sleep

Depression

Time Frame: 6 months and 1 year

a depressed mood or loss of pleasure or interest in activities for long periods of time

Anxiety

Time Frame: 6 months and 1 year

an emotion characterized by feelings of tension, worried thoughts, and physical changes like increased blood pressure

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Azienda Socio Sanitaria Territoriale di Lecco
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vincenzo Damico

Registered Nurse (RN), Doctor of Philosophy (PhD), Department of Anesthesia and Critical Care

Azienda Socio Sanitaria Territoriale di Lecco

Study Sites (2)

Loading locations...

Similar Trials